Kolettis Theofilos M, Agelaki Maria G, Baltogiannis Giannis G, Vlahos Antonios P, Mourouzis Iordanis, Fotopoulos Andreas, Pantos Constantinos
Department of Cardiology, University of Ioannina, 1 Stavrou Niarxou Avenue, 45110 Ioannina, Greece.
Europace. 2007 Nov;9(11):1099-104. doi: 10.1093/europace/eum196. Epub 2007 Sep 21.
This study investigated whether chronic and acute amiodarone treatment has differential effects on ventricular arrhythmogenesis during acute myocardial infarction in rats.
Forty-six rats were randomly allocated into vehicle, chronic oral amiodarone (30 mg/kg daily for 2 weeks), or acute amiodarone (a single dose, 100 mg/kg). Five additional rats were sham-operated. Myocardial infarction was generated by left coronary artery ligation 2 weeks after chronic treatment. Amiodarone was administered acutely 5 min post-ligation. The electrocardiogram was recorded for 24 h, using an implanted telemetry transmitter. Episodes of ventricular tachyarrhythmias and mortality rates were analysed. Serum catecholamines and infarct size were measured 24 h post-ligation. No differences were found in infarct size. Compared with controls (22.7 +/- 10.9), there was a similar reduction in the number of tachyarrhythmia episodes after either chronic (2.6 +/- 1.6, P = 0.0011) or acute (3.6 +/- 1.7, P = 0.031) amiodarone administration. Norepinephrine levels were lower only after chronic treatment. Mortality in both amiodarone treatment arms was exclusively due to bradyarrhythmia secondary to cardiac failure, whereas mortality in controls was mainly attributed to tachyarrhythmic death.
A rapid antiarrhythmic effect was observed after acute amiodarone administration in the rat. Norepinephrine levels decreased after chronic treatment and may be associated with bradyarrhythmic mortality.
本研究调查了慢性和急性胺碘酮治疗对大鼠急性心肌梗死期间室性心律失常发生的影响是否存在差异。
46只大鼠被随机分为溶剂对照组、慢性口服胺碘酮组(每日30mg/kg,持续2周)或急性胺碘酮组(单次剂量100mg/kg)。另外5只大鼠进行假手术。慢性治疗2周后通过结扎左冠状动脉诱导心肌梗死。在结扎后5分钟急性给予胺碘酮。使用植入式遥测发射器记录心电图24小时。分析室性快速心律失常发作情况和死亡率。在结扎后24小时测量血清儿茶酚胺和梗死面积。梗死面积未发现差异。与对照组(22.7±10.9)相比,慢性(2.6±1.6,P = 0.0011)或急性(3.6±1.7,P = 0.031)胺碘酮给药后快速心律失常发作次数均有类似减少。仅在慢性治疗后去甲肾上腺素水平降低。两个胺碘酮治疗组的死亡均完全归因于心力衰竭继发的缓慢性心律失常,而对照组的死亡主要归因于快速心律失常死亡。
在大鼠中急性给予胺碘酮后观察到快速抗心律失常作用。慢性治疗后去甲肾上腺素水平降低,可能与缓慢性心律失常死亡有关。